Determination of vitamin D and analysis of risk factors for osteoporosis in patients with chronic pain
- PMID: 32548145
- PMCID: PMC7281063
- DOI: 10.12998/wjcc.v8.i11.2150
Determination of vitamin D and analysis of risk factors for osteoporosis in patients with chronic pain
Abstract
Background: Vitamin D deficiency is common in patients with chronic pain and healthy people, but the difference between the two has not been reported; thus, whether there is a relationship between vitamin D deficiency and chronic pain remains to be confirmed. Osteoporosis is a common disease in chronic pain disorders. Understanding the relationship between vitamin D and osteoporosis will provide a basis for the rational supplementation of vitamin D to prevent osteoporosis, and to understand the risk factors of bone mass change to provide a new treatment plan for early prevention of osteoporosis.
Aim: To determine 25 hydroxy vitamin D (25OHD) level in patients with chronic pain to clarify its clinical significance. The relationship between vitamin D and bone mineral density (BMD) and the risk factors for bone mass change were also evaluated.
Methods: In this study, 184 patients with chronic pain were included in the study group, and 104 healthy individuals who underwent routine health checkups during the same period were included in the control group. 25OHD level was detected in both groups by enzyme-linked immunosorbent assay. According to the BMD test results, the patients in the study group were further classified into three subgroups: Normal BMD group, reduced BMD group, and osteoporosis group. Age, sex, ethnicity, living altitude, body mass index, 25OHD level, parathyroid hormone (PTH), calcium (Ca) and phosphorus levels were analyzed statistically in both groups.
Results: The vitamin D level in the study group was lower than that in the control group at 53.8% vs 57.7%, with no significant difference between the two groups. The proportion of patients with severe vitamin D deficiency in the study group was higher than that in the control group. The mean age was greater in the osteoporosis subgroup, and the youngest in the normal BMD subgroup. Vitamin D level in the osteoporosis subgroup was lower than that in the other two subgroups, and was not specific for the diagnosis of bone mass reduction and osteoporosis. The above results were analyzed statistically and showed significant differences (P < 0.05). There was a positive correlation between age and BMD in patients with chronic pain (R = 0.567, P < 0.001). Age, PTH and Ca were risk factors for bone mass reduction, while age, ethnicity and altitude were risk factors for osteoporosis.
Conclusion: Vitamin D deficiency is a common phenomenon in patients with chronic pain, and severe vitamin D deficiency is not uncommon. Vitamin D level is not a risk factor for bone mass reduction and osteoporosis. Bone mass reduction is correlated with age, PTH and Ca, while osteoporosis is correlated with age, ethnicity and altitude.
Keywords: Bone mass reduction; Bone mineral density; Chronic pain; Osteoporosis; Vitamin D deficiency.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
Figures
Similar articles
-
Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.Calcif Tissue Int. 1999 Jul;65(1):23-8. doi: 10.1007/s002239900652. Calcif Tissue Int. 1999. PMID: 10369729
-
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.J Clin Endocrinol Metab. 2001 Mar;86(3):1212-21. doi: 10.1210/jcem.86.3.7327. J Clin Endocrinol Metab. 2001. PMID: 11238511 Clinical Trial.
-
Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.Arch Osteoporos. 2017 Dec;12(1):13. doi: 10.1007/s11657-017-0306-7. Epub 2017 Jan 26. Arch Osteoporos. 2017. PMID: 28124221 Free PMC article.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Musculoskeletal Complications of Celiac Disease: A Case-Based Review.Mediterr J Rheumatol. 2023 Mar 31;34(1):86-90. doi: 10.31138/mjr.34.1.86. eCollection 2023 Mar. Mediterr J Rheumatol. 2023. PMID: 37223588 Free PMC article. Review.
Cited by
-
Association between serum phosphorus levels and pelvic bone mineral density in U.S. adults aged 18-59 years.BMC Musculoskelet Disord. 2025 Jul 7;26(1):665. doi: 10.1186/s12891-025-08838-y. BMC Musculoskelet Disord. 2025. PMID: 40624495 Free PMC article.
-
Low bone mineral density and its related factors in adults with congenital heart disease in Vietnam: A cross-sectional study.Health Sci Rep. 2022 Aug 7;5(5):e732. doi: 10.1002/hsr2.732. eCollection 2022 Sep. Health Sci Rep. 2022. PMID: 35949678 Free PMC article.
References
-
- Al-Jarallah KF, Shehab D, Al-Awadhi A, Nahar I, Haider MZ, Moussa MA. Are 25(OH)D levels related to the severity of knee osteoarthritis and function? Med Princ Pract. 2012;21:74–78. - PubMed
-
- Eloqayli H, Al-Yousef A, Jaradat R. Vitamin D and ferritin correlation with chronic neck pain using standard statistics and a novel artificial neural network prediction model. Br J Neurosurg. 2018;32:172–176. - PubMed
-
- Ortega Anta RM, González-Rodríguez LG, Jiménez Ortega AI, Estaire Gómez P, Rodríguez-Rodríguez E, Perea Sánchez JM, Aparicio Vizuete A, Grupo de Investigación Nº 920030. [Insufficient intake of vitamin D in spanish schoolchildren: determinants of the problem and basis for its improvement] Nutr Hosp. 2012;27:1437–1443. - PubMed
LinkOut - more resources
Full Text Sources